nach oben

Journal of Cancer Survivorship

Erschienen in:

06.04.2019

Associations between e-cigarette and combustible cigarette use among U.S. cancer survivors: implications for research and practice

verfasst von: Godfred O. Antwi, David K. Lohrmann, Wasantha Jayawardene, Angela Chow, Cecilia S. Obeng, Aaron M. Sayegh

Erschienen in: Journal of Cancer Survivorship | Ausgabe 2/2019

Einloggen, um Zugang zu erhalten

Abstract

Purpose

Prior studies established significant associations between e-cigarette use and combustible cigarette smoking in the general population; however, little is known about such associations among cancer survivors. Thus, the current study examined possible associations between e-cigarette use and combustible cigarette smoking among U.S. cancer survivors.

Methods

Cross-sectional data were drawn from the 2016 Behavioral Risk Factor Surveillance System Survey. Binary logistic regression was used to analyze the associations between e-cigarette user status and combustible cigarette-smoking status in a sample of 4680 cancer survivors, controlling for alcohol use and sociodemographic factors. Analyses were weighted for unequal probability of sample selection to reflect national cancer survivor population estimates.

Results

Prevalence for current e-cigarette use and combustible cigarette smoking for cancer survivors was 2.57% and 16.16%, respectively. In the adjusted analyses, cancer survivors who reported current e-cigarette use, compared to never-users, had greater odds of being current combustible cigarette smokers (odds ratio [OR] = 11.81, 95% confidence interval [CI] = 5.38–25.93). Likewise, former e-cigarette users, compared to never-users, had greater odds of being current combustible cigarette smokers (OR = 15.90, 95% CI = 10.68–23.36).

Conclusion

Among cancer survivors in the USA, e-cigarette use had a positive and highly significant association with combustible cigarette smoking.

Implications for Cancer Survivors

In order to prevent multiple and substitute use of nicotine-delivery products, prevention interventions and cessation programs designed for cancer survivors should specifically target both current combustible cigarette smokers and non-smokers who report former and current e-cigarette use.

Cancer treatment|survivor facts & figures. Am Cancer Soc https://www.cancer.org/research/cancer-facts-statistics/survivor-facts-figures.html. Accessed June 12, 2018.

American Cancer Society. Cancer facts & figures 2018. Atlanta: American Cancer Society; 2018.

NIH fact sheets—cancer. National Institutes of Health. https://report.nih.gov/nihfactsheets/viewfactsheet.aspx?csid=75. Accessed June 5, 2018.

Siegel RL, Miller KD, Jemal A. Cancer statistics, 2017. CA Cancer J Clin. 2017;67:7–30.CrossRefPubMed

Park SA, Chung SH, Lee Y. Factors associated with suicide risk in advanced cancer patients: a cross-sectional study. Asian Pac J Cancer Prev. 2016;17(11):4831–6. https://doi.org/10.22034/APJCP.2016.17.11.4831.CrossRefPubMedPubMedCentral

Phillips SM, Padgett LS, Leisenring WM, Stratton KK, Bishop K, Krull KR, et al. Survivors of childhood cancer in the United States: prevalence and burden of morbidity. Cancer Epidemiol Biomark Prev. 2015;24(4):653–63. https://doi.org/10.1158/1055-9965.epi-14-1418.CrossRef

Peppone LJ, Mustian KM, Morrow GR, Dozier AM, Ossip DJ, Janelsins MC, et al. The effect of cigarette smoking on cancer treatment-related side effects. Oncologist. 2011;16(12):1784–92. https://doi.org/10.1634/theoncologist.2011-0169.CrossRefPubMedPubMedCentral

Zon RT, Goss E, Vogel VG, Chlebowski RT, Jatoi I, Robson ME, et al. American Society of Clinical Oncology policy statement: the role of the oncologist in cancer prevention and risk assessment. J Clin Oncol. 2009;27(6):986–93. https://doi.org/10.1200/JCO.2008.16.3691.CrossRefPubMed

U.S. Department of Health and Human Services. The health consequences of smoking—50 years of progress: a report of the surgeon general, 2014. Atlanta: U.S. Department of Health and Human Services, Centers for Disease Control and Prevention, National Center for Chronic Disease Prevention and Health Promotion, Office on Smoking and Health; 2014.

10.

Cancer Trends Progress Report. Cancer survivors and smoking. https://progressreport.cancer.gov/after/smoking. Accessed May 30, 2018.

11.

King BA, Alam S, Promoff G, Arrazola R, Dube SR. Awareness and ever-use of electronic cigarettes among U.S. adults, 2010-2011. Nicotine Tob Res. 2013;15(9):1623–7. https://doi.org/10.1093/ntr/ntt013.CrossRefPubMed

12.

U.S. Department of Health and Human Services. E-cigarette use among youth and young adults. A report of the Surgeon General. Atlanta: U.S. Department of Health and Human Services, Centers for Disease Control and Prevention, National Center for Chronic Disease Prevention and Health Promotion, Office on Smoking and Health; 2016.

13.

Wilson FA, Wang Y. Recent findings on the prevalence of e-cigarette use among adults in the U.S. Am J Prev Med. 2017;52(3):385–90. https://doi.org/10.1016/j.amepre.2016.10.029.CrossRefPubMed

14.

Salloum RG, Getz KR, Tan AS, et al. Use of electronic cigarettes among CS in the U.S. Am J Prev Med. 2016;51(5):762–6. https://doi.org/10.1016/j.amepre.2016.04.015.CrossRefPubMed

15.

Leventhal AM, Strong DR, Kirkpatrick MG, Unger JB, Sussman S, Riggs NR, et al. Association of electronic cigarette use with initiation of combustible tobacco product smoking in early adolescence. JAMA. 2015;314(7):700–7. https://doi.org/10.1001/jama.2015.8950.CrossRefPubMedPubMedCentral

16.

Barrington-Trimis JL, Urman R, Berhane K, Unger JB, Cruz TB, Pentz MA, et al. E-cigarettes and future cigarette use. Am Acad Pediatr. 2016;138:e20160379. https://doi.org/10.1542/peds.2016-0379. CrossRef

17.

Wills TA, Knight R, Sargent JD, Gibbons FX, Pagano I, Williams RJ. Longitudinal study of e-cigarette use and onset of cigarette smoking among high school students in Hawaii. Tob Control. 2016;26(1):34–9. https://doi.org/10.1136/tobaccocontrol-2015-052705.CrossRefPubMed

18.

Rigotti NA. E-cigarette use and subsequent tobacco use by adolescents. JAMA. 2015;314(7):673–4. https://doi.org/10.1001/jama.2015.8382.CrossRefPubMed

19.

Borderud SP, Li Y, Burkhalter JE, Sheffer CE, Ostroff JS. Electronic cigarette use among patients with cancer: characteristics of electronic cigarette users and their smoking cessation outcomes. Cancer. 2014;120(22):3527–35. https://doi.org/10.1002/cncr.28811.CrossRefPubMed

20.

Behavioral Risk Factor Surveillance System. Centers for Disease Control and Prevention https://www.cdc.gov/brfss/annual_data/annual_2016.html. Published December 6, 2017. Accessed May 21, 2018.

21.

Centers for Disease Control and Prevention. Behavioral Risk Factor Surveillance System, 2016 Summary Data Quality Report. 2017. https://www.cdc.gov/brfss/annual_data/2016/pdf/2016-sdqr.pdf. Accessed 21 Aug 2018.

22.

Soneji S, Barrington-Trimis JL, Wills TA, Leventhal AM, Unger JB, Gibson LA, et al. Association between initial use of e-cigarettes and subsequent cigarette smoking among adolescents and young adults: a systematic review and meta-analysis. JAMA Pediatr. 2017;171(8):788–97. https://doi.org/10.1001/jamapediatrics.2017.1488.CrossRefPubMedPubMedCentral

23.

Smoking & tobacco use. Centers for Disease Control and Prevention. https://www.cdc.gov/tobacco/data_statistics/fact_sheets/adult_data/cig_smoking/index.htm. Published February 15, 2018. Accessed June 5, 2018.

24.

Clearing the smoke. Nature Neuroscience. July 2014. https://www.nature.com/articles/nn.3777. Accessed June 15, 2018.

25.

E-cigarettes and lung health. American Lung Association. http://www.lung.org/stop-smoking/smoking-facts/e-cigarettes-and-lung-health.html. Accessed September 5, 2018.

26.

Xu Y, Guo Y, Liu K, Liu Z, Wang X. E-cigarette awareness, use, and harm perception among adults: a meta-analysis of observational studies. Gorlova OY, ed. PLoS One. 2016;11(11):e0165938. https://doi.org/10.1371/journal.pone.0165938.CrossRefPubMedPubMedCentral

27.

Gallus S, Lugo A, Pacifici R, Pichini S, Colombo P, Garattini S, et al. E-cigarette awareness, use, and harm perceptions in Italy: a national representative survey. Nicotine Tob Res. 2014;16(12):1541–8. https://doi.org/10.1093/ntr/ntu124.CrossRefPubMed

28.

Pasquereau A, Guignard R, Andler R, Nguyen-Thanh V. Electronic cigarettes, quit attempts and smoking cessation: a 6-month follow-up. Addiction. 2017;112(9):1620–8. https://doi.org/10.1111/add.13869.CrossRefPubMed

29.

Farsalinos K. Electronic cigarettes: an aid in smoking cessation, or a new health hazard? Ther Adv Respir Dis. 2017;12:175346581774496. https://doi.org/10.1177/1753465817744960.CrossRef

30.

Adriaens K, Van Gucht D, Declerck P, Baeyens F. Effectiveness of the electronic cigarette: an eight-week Flemish study with six-month follow-up on smoking. Reduction, craving and experienced benefits and complaints. Farsalinos K, ed. Int J Environ Res Public Health. 2014;11(11):11220–48. https://doi.org/10.3390/ijerph111111220. CrossRefPubMedPubMedCentral

31.

Bullen C, Howe C, Laugesen M. Electronic cigarettes for smoking cessation: a randomised controlled trial. J Vasc Surg. 2014;59(3):872. https://doi.org/10.1016/j.jvs.2014.01.028.CrossRef

32.

Van Gucht D, Adriaens K, Baeyens F. Online vape shop customers who use E-cigarettes report abstinence from smoking and improved quality of life, but a substantial minority still have vaping-related health concerns. Int J Environ Res Public Health. 2017;14(7):798. https://doi.org/10.3390/ijerph14070798.CrossRefPubMedCentral

33.

Burke L, Miller L-A, Saad A, Abraham J. Smoking behaviors among cancer survivors: an observational clinical study. J Oncol Pract. 2009;5(1):6–9. https://doi.org/10.1200/jop.0912001.CrossRefPubMedPubMedCentral

34.

Toll BA, Brandon TH, Gritz ER, Warren GW, Herbst RS AACR Subcommittee on Tobacco and Cancer. Assessing tobacco use by cancer patients and facilitating cessation: an American Association for Cancer Research policy statement. Clin Cancer Res. 2013;19:1941–8.CrossRefPubMedPubMedCentral

35.

Huang J, Chaloupka FJ, Fong GT. Cigarette graphic warning labels and smoking prevalence in Canada: a critical examination and reformulation of the FDA regulatory impact analysis. Tob Control. 2014;23(0 1):i7–12. https://doi.org/10.1136/tobaccocontrol-2013-051170.CrossRefPubMed

36.

Hartmann-Boyce J, Chepkin SC, Ye W, Bullen C, Lancaster T. Nicotine replacement therapy versus control for smoking cessation. Cochrane Database Syst Rev. 2018. https://doi.org/10.1002/14651858.cd000146.pub5.

37.

Westmaas JL, Berg CJ, Alcaraz KI, Stein K. Health behavior theory constructs and smoking and cessation-related behavior among cancer survivors of ten cancers nine years after diagnosis: a report from the American Cancer Society Study of CS-I. Psycho-Oncology. 2015;24(10):1286–94. https://doi.org/10.1002/pon.3885.CrossRef

38.

Kaul S, Veeranki SP, Rodriguez AM, Kuo Y-F. Cigarette smoking, comorbidity, and general health among CS of adolescent and young adult cancer. Cancer. 2016;122(18):2895–905. https://doi.org/10.1002/cncr.30086.CrossRefPubMed

39.

Tao L, Wang R, Gao Y-T, Yuan J-M. Impact of post-diagnosis smoking on long-term survival of cancer patients: the Shanghai Cohort Study. Cancer Epidemiol Biomark Prev. 22(12):2404–11. https://doi.org/10.1158/1055-9965.EPI-13-0805-T.

40.

Park JJ, Park HA. Prevalence of cigarette smoking among adult CS in Korea. Yonsei Med J. 2015;56(2):556–62. https://doi.org/10.3349/ymj.2015.56.2.556.CrossRefPubMedPubMedCentral

41.

Health risks of smoking tobacco. American Cancer Society. https://www.cancer.org/cancer/cancer-causes/tobacco-and-cancer/health-risks-of-smoking-tobacco.html. Accessed May 21, 2018.

42.

Cigarette smoking and health. Encyclopedia of behavioral hedicine. 2013;421–421. https://doi.org/10.1007/978-1-4419-1005-9_100302.

43.

Alzahrani T, Pena I, Temesgen N, Glantz SA. Association between electronic cigarette use and myocardial infarction. Am J Prev Med. 2018;55(4):455–61. https://doi.org/10.1016/j.amepre.2018.05.004.CrossRefPubMedPubMedCentral

44.

Jamal A, Agaku IT, O’Connor E, King BA, Kenemer JB, Neff L. Current cigarette smoking among adults—United States, 2005–2013. MMWR Morb Mortal Wkly Rep. 2014;63(47):1108–12.PubMedPubMedCentral

45.

Schnoll RA, Goelz PM, Veluz-Wilkins A, Blazekovic S, Powers L, Leone FT, et al. Long-term nicotine replacement therapy: a randomized clinical trial. JAMA Intern Med. 2015;175(4):504–11. https://doi.org/10.1001/jamainternmed.2014.8313.CrossRefPubMedPubMedCentral

46.

Prochaska JJ, Benowitz NL. The past, present, and future of nicotine addiction therapy. Annu Rev Med. 2016;67:467–86. https://doi.org/10.1146/annurev-med-111314-033712.CrossRefPubMed

47.

Song AV, Morrell HER, Cornell JL, Ramos ME, Biehl M, Kropp RY, et al. Perceptions of smoking-related risks and benefits as predictors of adolescent smoking initiation. Am J Public Health. 2009;99(3):487–92. https://doi.org/10.2105/ajph.2008.137679.CrossRefPubMedPubMedCentral

48.

Aryal UR, Bhatta DN. Perceived benefits and health risks of cigarette smoking among young adults: insights from a cross-sectional study. Tob Induc Dis. 2015;13(1). https://doi.org/10.1186/s12971-015-0044-9.

49.

Sharma M, Khubchandani J, Nahar VK. Applying a new theory to smoking cessation: case of multi-theory model (MTM) for health behavior change. Health Promot Perspect. 2017;7(2):102–5. https://doi.org/10.15171/hpp.2017.18.CrossRefPubMedPubMedCentral

50.

Roberts NJ, Kerr SM, Smith SM. Behavioral interventions associated with smoking cessation in the treatment of tobacco use. Health Serv Insights. 2013;6:HSI.S11092. https://doi.org/10.4137/hsi.s11092.CrossRef

51.

Fiore MC, Jaen CR, Baker TB, et al. Treating tobacco use and dependence: 2008 update. Clinical Practice Guideline. Rockville: US Public Health Service; 2008.

52.

Li X, Li Q, Dong L, Sun B, Chen J, Jiang Y, et al. Risk factors associated with smoking behaviour in recreational venues: findings from the International Tobacco Control (ITC) China Survey. Tob Control. 2009;19(Supplement 2):i30–9. https://doi.org/10.1136/tc.2009.031336.CrossRefPubMed

53.

Kim H, Kim M-H, Park Y-S, Shin JY, Song Y-M. Factors that predict persistent smoking of CS. J Korean Med Sci. 2015;30(7):853–9. https://doi.org/10.3346/jkms.2015.30.7.853.CrossRefPubMedPubMedCentral

Titel: Associations between e-cigarette and combustible cigarette use among U.S. cancer survivors: implications for research and practice
verfasst von: Godfred O. Antwi
David K. Lohrmann
Wasantha Jayawardene
Angela Chow
Cecilia S. Obeng
Aaron M. Sayegh
Publikationsdatum: 06.04.2019
Verlag: Springer US
Erschienen in: Journal of Cancer Survivorship / Ausgabe 2/2019
Print ISSN: 1932-2259
Elektronische ISSN: 1932-2267
DOI: https://doi.org/10.1007/s11764-019-00753-1

Dual cigarette and e-cigarette use in cancer survivors: an analysis using Population Assessment of Tobacco Health (PATH) data

Finding sexual health aids after cancer: are cancer centers supporting survivors’ needs?

Receipt of a survivorship care plan and self-reported health behaviors among cancer survivors

Prostate cancer and subsequent nutritional outcomes: the role of diagnosis and treatment

Cognitive functioning in thyroid cancer survivors: a systematic review and meta-analysis

Review

Hospitalization rate in offspring of cancer survivors: a national cohort study

Open Access

Neu im Fachgebiet Onkologie

Duale Checkpointhemmung gegen Melanome verlängert langfristig das Leben

15.01.2025
Melanom
Nachrichten

Im Vergleich zu den Überlebenschancen vor der Einführung von Immuncheckpointhemmern (ICI) ist der Fortschritt durch eine ICI-Kombination mit unterschiedlichen Tagets bei fortgeschrittenem Melanom erstaunlich. Das belegen die finalen Ergebnisse der CheckMate-067-Studie und geben Betroffenen "Hoffnung auf Heilung".

Knochenmarktransplantat als Chance für ältere AML-Patienten

15.01.2025
Akute myeloische Leukämie
Nachrichten

Lange Zeit ist die Transplantation von hämatopoetischen Stammzellen nur bei jüngeren Patienten mit akuter myeloischer Leukämie praktiziert worden. Inzwischen profitieren auch Ältere davon. Ergebnisse einer Studie unterstützen dieses Vorgehen.

Nierenzellkarzinom: Kein Nachteil durch subkutan appliziertes Nivolumab

14.01.2025
Nierenkarzinom
Nachrichten

Die subkutane Applikation von Nivolumab ist nach Daten einer Phase-3-Studie ähnlich gut wirksam wie die intravenöse: Die Pharmakokinetik ist vergleichbar, die objektive Response war in der Studie sogar leicht besser als in der Gruppe mit Infusionen.

Vorteile für Androgenentzug plus Androgenrezeptorblockade

14.01.2025
Prostatakarzinom
Nachrichten

Für Männer mit metastasiertem hormonsensitivem Prostata-Ca. (mHSPC), die keine Hormonchemotherapie wollen oder vertragen, ist der Androgenentzug plus Darolutamid eine Alternative: Das Progressionsrisiko wird im Vergleich zum alleinigen Androgenentzug fast halbiert.

Update Onkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen

Springer Medizin

Associations between e-cigarette and combustible cigarette use among U.S. cancer survivors: implications for research and practice